NSE ScannerComparison · NSE · data 2026-11-01
Gufic Biosciences Limited vs Gujarat Themis Biosyn Ltd
In plain words
Size: Gujarat Themis Biosyn Ltd is about 1.1 times the market value of Gufic Biosciences Limited.
Valuation (P/E): Gujarat Themis Biosyn Ltd 81.3 vs Gufic Biosciences Limited 56.5.
Return on equity: Gujarat Themis Biosyn Ltd 17.4% vs Gufic Biosciences Limited 10.1%.
Differences in the numbers, not a recommendation of either stock.
Side by side
| GUFICBIO | GUJTHEM | |
|---|---|---|
| Price | ₹413.55 | ₹363.2 |
| Market cap | ₹4,134 cr | ₹4,718 cr |
| P/E | 56.5 | 81.3 |
| P/B | — | — |
| ROE | 10.1% | 17.4% |
| ROCE | 15.3% | 18.2% |
| Debt / equity | 0.61 | 0.56 |
| Operating margin | 13.6% | 38.9% |
| Dividend yield | 0.02% | 0.18% |
| Sales growth, 3 years (yearly) | 11.0% | 3.8% |
| Profit growth, 3 years (yearly) | -6.9% | -7.0% |
| 1-year return | 23.7% | -21.9% |
| Revenue, last 12 months | ₹981 cr | ₹174 cr |
| Net profit, last 12 months | ₹73 cr | ₹49 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹22 cr | — |
| Quarter profit vs a year earlier | +70.7% | — |
| Promoter holding | 72.50% | 59.33% |
| Health check | Average (5.7/10) | Weak (3.7/10) |
Common questions
Which has a higher P/E, Gufic Biosciences Limited or Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd trades at the higher P/E (81.3 against 56.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Gujarat Themis Biosyn Ltd (17.4% against 10.1%).
Which carries more debt?
Gufic Biosciences Limited has the higher debt-to-equity ratio (0.61 against 0.56).